Air Products & Chemicals, Inc. vs BioNano Genomics Inc — how do they compare? Air Products & Chemicals, Inc. trades at $308.56 (market cap $68.88B), while BioNano Genomics Inc trades at $1.19 (market cap $13.66M). The key difference: Air Products & Chemicals, Inc. is far larger — about 5042.5× BioNano Genomics Inc's market cap, and Air Products & Chemicals, Inc. pays a 2.34% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| APD | BNGO | |
|---|---|---|
Market Cap | $68.88B | $13.66M |
Sector | Basic Materials | Health |
52-Week High | $314.19 | $4.92 |
52-Week Low | $230.42 | $1.06 |
Enterprise Value | $86.06B | $16.26M |
Dividend Yield | 2.34% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
Trailing returns across standard periods
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →